Navigation Links
Foundation Venture Capital Group, LLC Invests in Start Up Committed to Breast Cancer Diagnostics
Date:9/28/2007

NEW BRUNSWICK, N.J., Sept. 28 /PRNewswire-USNewswire/ -- James M. Golubieski, president of Foundation Venture Capital Group, LLC, announced today that the company has made a $500,000 commitment to CellXplore, Inc., a start-up company at the University of Medicine & Dentistry of New Jersey (UMDNJ) committed to breast cancer diagnostics.

Kiran Madura, Ph.D., chief scientific officer of CellXplore and professor in the Department of Biochemistry at UMDNJ-Robert Wood Johnson Medical School (RWJMS), founded the company.

CellXplore has identified several biomarkers that could help in the non- invasive diagnosis of breast cancer, using a biochemical analysis of blood samples to identify specific proteins found in those who have the disease. According to Dr. Madura, the eventual hope is that the strategy would not only be able to help diagnose breast and other cancers but might also be able to discriminate between different types and stages, which would be helpful in establishing targeted treatment plans for patients.

"While we are currently focusing on breast cancer biomarkers, in the future we will investigate whether blood sample biomarkers can also be identified for the early diagnosis of major, debilitating illnesses such as muscle wasting disease and neurodegenerative conditions including Alzheimer's and Parkinson's Disease," he explained.

George F. Heinrich, M.D., vice chair and CEO of Foundation Venture Capital Group, is enthusiastic about this new company and what the investment means for the University.

"Our investment in CellXplore reinforces our strong relationship with UMDNJ and our willingness to invest in companies that might not otherwise receive support at this early stage," said Dr. Heinrich. "Dr. Madura and his company are developing very promising technology that has great potential in the diagnosis of cancer and other devastating diseases."

Foundation Venture Capital Group was founded in 2006 to invest in commercially viable new start-up companies developing technology at the University of Medicine & Dentistry of New Jersey. CellXplore is its second investment within the past six months.


'/>"/>
SOURCE Foundation Venture Capital Group, LLC
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Woodruff Foundation Grant To Support Doctorate Of Nursing Practice Program
2. Kalam To Lay Foundation Of Vellore Research Center
3. Nippon Foundation To Help Leprosy Patients
4. Parents Launch SV40 Cancer Foundation In Memory of Son
5. Cancer Aid And Research Foundation: Offering Endless Hope To Cancer Patients
6. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
7. PM Launches Healthcare Foundation For India
8. Prime Minister Manmohan Singh, Flags Off Public Health Foundation of India
9. Gates Foundation to donate USD 104 million to TB Alliance
10. MoU for HIV/AIDS Signed by Nigeria and Clinton Foundation
11. Gates Foundation Adopts Fight against Encephalitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... ... April 28, 2016 , ... CastCoverz!, America’s #1 trusted brand ... country's oldest waterproof cast protector . As the largest one-stop, orthopedic shop, ... of daily, night, weatherproof and waterproof covers for most orthopedic devices, including but ...
(Date:4/28/2016)... ... April 28, 2016 , ... University of New England President Danielle N. Ripich ... president of Student Engagement. In addition to his role as director of Athletics, ... , “In the space of just one year Jack has distinguished himself by ...
(Date:4/28/2016)... ... 2016 , ... The ARRS 2016 Annual Meeting ... from around the globe who attended a week’s worth of cutting-edge scientific presentations, ... included the introduction of the 2016 ARRS Distinguished Educator, Dr. Gerald F. Abbott, ...
(Date:4/28/2016)... D.C., (PRWEB) , ... April 28, 2016 , ... ... systems, and the Campaign for Tobacco-Free Kids, a leading force in the fight ... promote federal, state and local policies that can help reduce tobacco use. The ...
(Date:4/28/2016)... ... , ... In many parts of the world, contamination from human waste is ... true in underdeveloped parts of Africa where clean sources of food and water are ... Morocco, will examine this global health issue and consider how it compares to other ...
Breaking Medicine News(10 mins):
(Date:4/27/2016)... Oasmia Pharmaceutical AB (NASDAQ: ... new generation of drugs within human and veterinary ... Paclical/Apealea in the Phase III study that included ... cancer. These preliminary results showed non-inferiority between the ... versus Taxol in combination with carboplatin. In fact, ...
(Date:4/26/2016)... -- Diplomat Pharmacy, Inc. (NYSE: DPLO) is pleased to ... D., to Vice President of Education and Quality. ... continue to lead and oversee Diplomat University, an innovative ... training to Diplomat employees and external professionals on topics ... houses the quality assurance department, which focuses on programs ...
(Date:4/26/2016)... , April 26, 2016 ... Assessment and Credit Risk Analysis of the Biological Medicine ... This comprehensive report analyzes the financial assessment and ... China . The report provides readers with ... topics all market participants should be aware of. It ...
Breaking Medicine Technology: